{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:28:22Z","timestamp":1761895702539},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T00:00:00Z","timestamp":1375660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1472-6947-13-83","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T16:14:14Z","timestamp":1375719254000},"source":"Crossref","is-referenced-by-count":9,"title":["Interdisciplinary decision making in prostate cancer therapy \u2013 5-years\u2019 time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charit\u00e9 Berlin"],"prefix":"10.1186","volume":"13","author":[{"given":"Daniel","family":"Baumunk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Reunkoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Kushner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Baumunk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Kempkensteffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Weikert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"H\u00f6cht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schostak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,5]]},"reference":[{"key":"737_CR1","volume-title":"Cancer in Germany 2007\/2008, Version 8","author":"GEKID","year":"2012","unstructured":"GEKID: Cancer in Germany 2007\/2008, Version 8. 2012, Berlin, Germany: Robert-Koch-Institute and the Association of Population-based Cancer Registries in Germany (GEKID)"},{"issue":"3","key":"737_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<295::AID-PATH663>3.0.CO;2-W","volume":"180","author":"ET Ruijter","year":"1996","unstructured":"Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ: Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol. 1996, 180 (3): 295-299. 10.1002\/(SICI)1096-9896(199611)180:3<295::AID-PATH663>3.0.CO;2-W.","journal-title":"J Pathol"},{"issue":"1","key":"737_CR3","first-page":"23","volume":"58","author":"CA Macintosh","year":"1998","unstructured":"Macintosh CA, Stower M, Reid N, Maitland NJ: Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res. 1998, 58 (1): 23-28.","journal-title":"Cancer Res"},{"issue":"2","key":"737_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.critrevonc.2011.11.001","volume":"83","author":"MA Kollmeier","year":"2012","unstructured":"Kollmeier MA, Zelefsky MJ: How to select the optimal therapy for early-stage prostate cancer. Crit Rev Oncol Hematol. 2012, 83 (2): 225-234. 10.1016\/j.critrevonc.2011.11.001.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"737_CR5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.eururo.2009.02.028","volume":"55","author":"PJ Bastian","year":"2009","unstructured":"Bastian PJ, Carter BH, Bjartell A, Seitz M, Stanislaus P, Montorsi F, Stief CG, Schroder F: Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol. 2009, 55 (6): 1321-1330. 10.1016\/j.eururo.2009.02.028.","journal-title":"Eur Urol"},{"issue":"32","key":"737_CR6","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.1200\/JCO.2005.03.3134","volume":"23","author":"L Klotz","year":"2005","unstructured":"Klotz L: Active surveillance for prostate cancer: for whom?. J Clin Oncol. 2005, 23 (32): 8165-8169. 10.1200\/JCO.2005.03.3134.","journal-title":"J Clin Oncol"},{"issue":"6","key":"737_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00345-004-0447-3","volume":"22","author":"M Schostak","year":"2004","unstructured":"Schostak M, Wiegel T, Muller M, Hoecht S, Schrader M, Straub B, Bottke D, Hinkelbein W, Miller K: Shared decision-making\u2013results from an interdisciplinary consulting service for prostate cancer. World J Urol. 2004, 22 (6): 441-448. 10.1007\/s00345-004-0447-3.","journal-title":"World J Urol"},{"key":"737_CR8","volume-title":"Interdisciplinary S3-guidelines on the early detection, diagnostics and therapy of the different stages of prostate cancer; AWMF registration number (034-022OL), Version 2.0","author":"DGU","year":"2011","unstructured":"DGU: Interdisciplinary S3-guidelines on the early detection, diagnostics and therapy of the different stages of prostate cancer; AWMF registration number (034-022OL), Version 2.0. 2011, D\u00fcsseldorf, Germany: Deutsche Gesellschaft f\u00fcr Urologie e. V. (German Urological Association)"},{"issue":"Suppl 3","key":"737_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1464-410X.2004.05136.x","volume":"94","author":"UW Tunn","year":"2004","unstructured":"Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int. 2004, 94 (Suppl 3): 6-","journal-title":"BJU Int"},{"issue":"9","key":"737_CR10","first-page":"501","volume":"35","author":"A Heidenreich","year":"2011","unstructured":"Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T: [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]. Actas Urol Esp. 2011, 35 (9): 501-514.","journal-title":"Actas Urol Esp"},{"issue":"2","key":"737_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"MS Cookson","year":"2007","unstructured":"Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J: Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007, 177 (2): 540-545. 10.1016\/j.juro.2006.10.097.","journal-title":"J Urol"},{"issue":"6","key":"737_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/GIM.0b013e3181a18982","volume":"11","author":"EA Lobb","year":"2009","unstructured":"Lobb EA, Gaff CL, Meiser B, Butow PN, Osseiran-Moisson R, Hallowell N: Attendance of men at the familial cancer clinic: what they value from the consultation. Genet Med. 2009, 11 (6): 434-440. 10.1097\/GIM.0b013e3181a18982.","journal-title":"Genet Med"},{"issue":"12","key":"737_CR13","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/S0277-9536(00)00303-8","volume":"52","author":"M Gattellari","year":"2001","unstructured":"Gattellari M, Butow PN, Tattersall MH: Sharing decisions in cancer care. Soc Sci Med. 2001, 52 (12): 1865-1878. 10.1016\/S0277-9536(00)00303-8.","journal-title":"Soc Sci Med"},{"issue":"5","key":"737_CR14","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.juro.2011.07.033","volume":"186","author":"TJ Daskivich","year":"2011","unstructured":"Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS: Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol. 2011, 186 (5): 1868-1873. 10.1016\/j.juro.2011.07.033.","journal-title":"J Urol"},{"issue":"9","key":"737_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","volume":"29","author":"JI Epstein","year":"2005","unstructured":"Epstein JI, Allsbrook WC, Amin MB, Egevad LL: The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005, 29 (9): 1228-1242. 10.1097\/01.pas.0000173646.99337.b1.","journal-title":"Am J Surg Pathol"},{"issue":"3 Pt B","key":"737_CR16","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.1111\/j.1464-410X.2012.11368.x","volume":"111","author":"I Kunz","year":"2013","unstructured":"Kunz I, Musch M, Roggenbuck U, Klevecka V, Kroepfl D: Tumour characteristics, oncological and functional outcomes in patients aged \u2265 70 years undergoing radical prostatectomy. BJU Int. 2013 Mar, 111 (3 Pt B): E24-E29. 10.1111\/j.1464-410X.2012.11368.x. Epub 2012 Sep 5. PMID: 22947135","journal-title":"BJU Int"},{"issue":"2","key":"737_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.urology.2009.07.1353","volume":"75","author":"CS Thaxton","year":"2010","unstructured":"Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ: Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols. Urol. 2010, 75 (2): 414-418. 10.1016\/j.urology.2009.07.1353.","journal-title":"Urol"},{"issue":"2","key":"737_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1369-7625.2004.00271.x","volume":"7","author":"D Feldman-Stewart","year":"2004","unstructured":"Feldman-Stewart D, Brundage MD, Van Manen L, Svenson O: Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid. Health Expect. 2004, 7 (2): 126-141. 10.1111\/j.1369-7625.2004.00271.x.","journal-title":"Health Expect"},{"key":"737_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1472-6947-9-47","volume":"9","author":"SH Meghani","year":"2009","unstructured":"Meghani SH, Lee CS, Hanlon AL, Bruner DW: Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities. BMC Med Inform Decis Mak. 2009, 9: 47-10.1186\/1472-6947-9-47.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"737_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1054\/bjoc.2000.1573","volume":"84","author":"V Jenkins","year":"2001","unstructured":"Jenkins V, Fallowfield L, Saul J: Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer. 2001, 84 (1): 48-51. 10.1054\/bjoc.2000.1573.","journal-title":"Br J Cancer"},{"issue":"3","key":"737_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1046\/j.1464-410x.2001.02046.x","volume":"87","author":"D Feldman-Stewart","year":"2001","unstructured":"Feldman-Stewart D, Brundage MD, Nickel JC, MacKillop WJ: The information required by patients with early-stage prostate cancer in choosing their treatment. BJU Int. 2001, 87 (3): 218-223. 10.1046\/j.1464-410x.2001.02046.x.","journal-title":"BJU Int"},{"issue":"6","key":"737_CR22","first-page":"5998","volume":"18","author":"D Feldman-Stewart","year":"2011","unstructured":"Feldman-Stewart D, Brundage MD, Tong C: Information that affects patients' treatment choices for early stage prostate cancer: a review. Can J Urol. 2011, 18 (6): 5998-6006.","journal-title":"Can J Urol"},{"issue":"1","key":"737_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1464-410X.2004.04553.x","volume":"93","author":"BJ Davison","year":"2004","unstructured":"Davison BJ, Parker PA, Goldenberg SL: Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int. 2004, 93 (1): 47-51. 10.1111\/j.1464-410X.2004.04553.x.","journal-title":"BJU Int"},{"issue":"9","key":"737_CR24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5694\/j.1326-5377.2005.tb06790.x","volume":"182","author":"PD Baade","year":"2005","unstructured":"Baade PD, Steginga SK, Pinnock CB, Aitken JF: Communicating prostate cancer risk: what should we be telling our patients?. Med J Aust. 2005, 182 (9): 472-475.","journal-title":"Med J Aust"},{"issue":"2","key":"737_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1464-410X.2012.11423.x","volume":"111","author":"MJ Resnick","year":"2013","unstructured":"Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF: Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int. 2013 Feb, 111 (2): 213-220. 10.1111\/j.1464-410X.2012.11423.x. Epub 2012 Aug 29. PMID: 22928860","journal-title":"BJU Int"},{"issue":"9","key":"737_CR26","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/cncr.21822","volume":"106","author":"SB Zeliadt","year":"2006","unstructured":"Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW: Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006, 106 (9): 1865-1874. 10.1002\/cncr.21822.","journal-title":"Cancer"},{"issue":"5","key":"737_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.urology.2007.01.027","volume":"69","author":"SL Snow","year":"2007","unstructured":"Snow SL, Panton RL, Butler LJ, Wilke DR, Rutledge RD, Bell DG, Rendon RA: Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer. Urol. 2007, 69 (5): 941-945. 10.1016\/j.urology.2007.01.027.","journal-title":"Urol"},{"issue":"2 Pt 2","key":"737_CR28","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1111\/j.1464-410X.2011.10791.x","volume":"110","author":"AC Goh","year":"2012","unstructured":"Goh AC, Kowalkowski MA, Bailey DE, Kazer MW, Knight SJ, Latini DM: Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. BJU Int. 2012, 110 (2 Pt 2): E50-E56.","journal-title":"BJU Int"},{"issue":"6","key":"737_CR29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/fampra\/cmg617","volume":"20","author":"H Cohen","year":"2003","unstructured":"Cohen H, Britten N: Who decides about prostate cancer treatment? A qualitative study. Fam Pract. 2003, 20 (6): 724-729. 10.1093\/fampra\/cmg617.","journal-title":"Fam Pract"},{"issue":"3","key":"737_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1464-4096.2001.01741.x","volume":"89","author":"SK Steginga","year":"2002","unstructured":"Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P: Making decisions about treatment for localized prostate cancer. BJU Int. 2002, 89 (3): 255-260. 10.1046\/j.1464-4096.2001.01741.x.","journal-title":"BJU Int"},{"issue":"1","key":"737_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pros.21406","volume":"72","author":"A Sidana","year":"2012","unstructured":"Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S, Epstein JI: Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate. 2012, 72 (1): 58-64. 10.1002\/pros.21406.","journal-title":"Prostate"},{"issue":"3","key":"737_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/cncr.22033","volume":"107","author":"TD Denberg","year":"2006","unstructured":"Denberg TD, Melhado TV, Steiner JF: Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer. 2006, 107 (3): 620-630. 10.1002\/cncr.22033.","journal-title":"Cancer"},{"key":"737_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1472-6947-12-52","volume":"12","author":"SK Linder","year":"2012","unstructured":"Linder SK, Swank PR, Vernon SW, Morgan RO, Mullen PD, Volk RJ: Is a prostate cancer screening anxiety measure invariant across two different samples of age-appropriate men?. BMC Med Inform Decis Mak. 2012, 12: 52-10.1186\/1472-6947-12-52.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"737_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/cncr.11065","volume":"97","author":"F Efficace","year":"2003","unstructured":"Efficace F, Bottomley A, van Andel G: Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer. 2003, 97 (2): 377-388. 10.1002\/cncr.11065.","journal-title":"Cancer"},{"issue":"16","key":"737_CR35","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","volume":"44","author":"G van Andel","year":"2008","unstructured":"van Andel G, Bottomley A, Fossa SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A: An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008, 44 (16): 2418-2424. 10.1016\/j.ejca.2008.07.030.","journal-title":"Eur J Cancer"},{"issue":"5","key":"737_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.zefq.2012.05.004","volume":"106","author":"M Stockle","year":"2012","unstructured":"Stockle M, Bussar-Maatz R: [Localised prostate cancer: the PREFERE trial]. Z Evid Fortbild Qual Gesundhwes. 2012, 106 (5): 333-335. 10.1016\/j.zefq.2012.05.004. discussion 335","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"issue":"1","key":"737_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.eururo.2011.08.042","volume":"61","author":"T Hambrock","year":"2012","unstructured":"Hambrock T, Hoeks C, Hulsbergen-Van De Kaa C, Scheenen T, Futterer J, Bouwense S, Van Oort I, Schroder F, Huisman H, Barentsz J: Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 2012, 61 (1): 177-184. 10.1016\/j.eururo.2011.08.042.","journal-title":"Eur Urol"},{"issue":"12","key":"737_CR38","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1158\/1078-0432.CCR-10-2650","volume":"17","author":"DC Danila","year":"2011","unstructured":"Danila DC, Fleisher M, Scher HI: Circulating tumor cells as biomarkers in prostate cancer. Clin Cancer Res. 2011, 17 (12): 3903-3912. 10.1158\/1078-0432.CCR-10-2650.","journal-title":"Clin Cancer Res"},{"key":"737_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-11-16","volume":"11","author":"HC Lin","year":"2011","unstructured":"Lin HC, Wu HC, Chang CH, Li TC, Liang WM, Wang JY: Development of a real-time clinical decision support system upon the Web MVC-based architecture for prostate cancer treatment. BMC Med Inform Decis Mak. 2011, 11: 16-10.1186\/1472-6947-11-16.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"737_CR40","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2196\/jmir.1891","volume":"14","author":"MA Diefenbach","year":"2012","unstructured":"Diefenbach MA, Mohamed NE, Butz BP, Bar-Chama N, Stock R, Cesaretti J, Hassan W, Samadi D, Hall SJ: Acceptability and preliminary feasibility of an internet\/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study. J Med Internet Res. 2012, 14 (1): e6-10.2196\/jmir.1891.","journal-title":"J Med Internet Res"},{"key":"737_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6947-10-12","volume":"10","author":"CS Dorfman","year":"2010","unstructured":"Dorfman CS, Williams RM, Kassan EC, Red SN, Dawson DL, Tuong W, Parker ER, Ohene-Frempong J, Davis KM, Krist AH: The development of a web- and a print-based decision aid for prostate cancer screening. BMC Med Inform Decis Mak. 2010, 10: 12-10.1186\/1472-6947-10-12.","journal-title":"BMC Med Inform Decis Mak"},{"key":"737_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1472-6947-12-130","volume":"12","author":"SL Sheridan","year":"2012","unstructured":"Sheridan SL, Golin C, Bunton A, Lykes JB, Schwartz B, McCormack L, Driscoll D, Bangdiwala SI, Harris RP: Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials. BMC Med Inform Decis Mak. 2012, 12: 130-10.1186\/1472-6947-12-130.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"7","key":"737_CR43","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/annonc\/mdr585","volume":"23","author":"RF Dear","year":"2012","unstructured":"Dear RF, Barratt AL, Askie LM, Butow PN, McGeechan K, Crossing S, Currow DC, Tattersall MH: Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Ann Oncol. 2012, 23 (7): 1912-1918. 10.1093\/annonc\/mdr585.","journal-title":"Ann Oncol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-13-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-13-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-13-83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-13-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T12:29:08Z","timestamp":1596284948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-13-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,5]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-13-83","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,5]]},"article-number":"83"}}